Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Orano Med LLC
RasCal Therapeutics, Inc.
Columbia University
Second Affiliated Hospital of Guangzhou Medical University
Fudan University
Jiujiang University Affiliated Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Fox Chase Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Envita Medical Center, Inc.
Pharmacyclics LLC.